Clinical Trials Browser

mirabegron × Genitourinary × Clear all

NCT03600766 2019-09-04

Mirabegron for Treatment of Erectile Dysfunction in Patients With LUTS Secondry to BPH: A Randomized Study

Phase 2 Unknown

Erectile Dysfunction, Prostatic Hyperplasia, Prostatic Neoplasms

NCT00410514 2014-04-04

A Study of Mirabegron (YM178) in Men With Lower Urinary Tract Symptoms (LUTS) and Bladder Outlet Obstruction (BOO)

Phase 2 Completed

200 enrolled 24 charts

EndocrineGenitourinary

Urinary Bladder Neck Obstruction, Multiple Endocrine Neoplasia Type 1, Lower Urinary Tract Symptoms